ArticleInternational urology and nephrology2026
A qualitative study on treatment decision-making experiences of primary caregivers of children with difficult-to-treat nephrotic syndrome.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study focuses on difficult-to-treat nephrotic syndrome (DTNS), a condition that imposes severe physical and psychological burdens on patients and their families, to assess the experiences and psychological states of primary caregivers during the treatment decision-making process.
methodsWe conducted semi-structured, in-depth interviews with 15 primary caregivers of children with difficult-to-treat nephrotic syndrome at a tertiary women's and children's hospital in China and analyzed the verbatim transcripts using inductive thematic analysis.
resultsThe primary caregivers had a mean age of 36 years, with approximately 73% being female; the children's average disease duration was 6 years, and 95% of families reported inadequate knowledge about the disease. Although 80% of families adopted combined immunosuppressive therapy, only 20% expressed satisfaction with the effectiveness of the treatment regimens. In the analysis of drug effects, 70% of caregivers believed that glucocorticoid therapy had significant efficacy, but 40% of families reported serious adverse effects that affected the child's quality of life; approximately 60% of caregivers mentioned a markedly increased infection risk associated with immunosuppressants; 75% of primary caregivers experienced considerable psychological pressure; and 60% exhibited emotional fluctuations when the condition relapsed.
conclusionThe findings reveal multiple challenges faced by caregivers in coping with DTNS, emphasizing the importance of information access, decision-making support for treatment, and psychological health services. Future research should explore effective strategies to improve support systems for patients and families, thereby enhancing clinical treatment quality and patient quality of life.
Indexed as
Identifiers
41774398What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.